维普期刊资源整合服务平台（V6.5）

22篇 您的检索式：作者名="Xiang XJ"

选中清除导出查看参考文献查看引证文献引用追踪共2页首页上一页第1页下一页末页 /2 跳转

	题名	作者	年代	出处	被引量
1	Discovery of (2,3-difluoro-6- methoxyphenyl)methanone (R547), a potent and selective cyclin-dependent kinase inhibitor with significant in vivo antitumor activity显示文摘	Chu XJ DePinto W Bartkovitz D So SS Vu BT Packman K Lukacs C Ding Q Jiang N Wang K Goelzer P Yin X Smith MA Higgins BX Chen Y Xiang Q Moliterni J Kaplan G Graves B Lovey A Fotouhi N	2006	J Med Chem2006，49，22：	1
2	Alcohol and alcohol- related harm in China:policy changes needed显示文摘	Tang YL Xiang XJ Wang XY et a/	2013	Bull World Health Organ2013，91，4：	1
3	Expression of a wheat cytochrome P450 monooxygenase cDNA in yeast catalyzes the metabolism of sulfonylurea herbicides 显示文摘	Xiang WS Wang XJ Ren TR	2006	Pestic Biochem Physiol2006，85，：	1
4	A phase II study of capecitabine plus oxaliplatin as first-line chemotherapy in elderly patients with advanced gastric cancer 显示文摘	Xiang XJ Zhang L Qiu F	2012	Chemotherapy2012，58，1：	1
5	Clinical study on IL-8,TNF-α,T-cell subgroup in serum of patients with rectal cancer显示文摘	Chen J Xiang F Tang XJ	2011	Chinese-German J Cl Onc2011，10，2：	1
6	A phase Ⅱ study of modified FOLFOX as first-line chemotherapy in advanced smal bowel ade-nocarcinoma显示文摘	Xiang XJ Liu YW Zhang L		0，，05：	1
7	miR-320 enhances the sensitivity of human colon cancer cells to chemoradiother- apy in vitro by targeting FOXMI显示文摘	Wan LY Deng J Xiang XJ	2015	Biochem Biophys Res Commun2015，457，2：	1
8	Overexpression of a miR393-resistant form of transport inhibitor response protein 1 (mTIR1) enhances salt tolerance by increased osmoregulation and Na+ exclusion in Arabidopsis thaliana 显示文摘	Chen ZH Hu LZ Han N Hu JQ Yang YJ Xiang TH Zhang XJ Wang LL	2014	Plant Cell Physiol2014，，：	1
9	A phaseⅡstudy of capecitabine plus oxaliplatin as first-line chemotherapy in elderly patients with advanced gastric cancer显示文摘	Xiang XJ Zhang L Qiu F	2012	Chemotherapy2012，58，1：	1
10	A Phase II Study of Capecitabine plus Oxaliplatin as First-Line Chemotherapy in Elderly Patients with Advanced Gastric Cancer显示文摘	Xiang XJ Zhang L Qiu F		0，，01：	1
11	A phase II study of capecitabine plus oxaliplatin as first-line chemotherapy in elderly patients with advanced gastric cancer 显示文摘	Xiang XJ Zhang L Qiu F	2012	Chemotherapy2012，58，1：	1
12	Differential expression of Dickkopf - 1 among non - small cell lung cancer cells 显示文摘	Xiang XJ Liu YW Chen DD	2015	Mol Med Rep2015，12，2：	1
13	A rapid lactate dehydrogenase histochemical method for the intraoperative assessment of Hirschsprung's disease显示文摘	Li N Xiang L Wu XJ	2012	Int J Colorectal Dis2012，27，9：	1
14	A phase II trial of epirubicin, oxaliplatin, and capecitabine (EOX) as first-line chemotherapy in advanced gastric cancer: a Chinese single- center experience 显示文摘	Xiang XJ Qiu F Xiong JP Zhang L	2010	Chemotherapy2010，56，：	1
15	Clinical study on IL-8, TNF-α, T-cell subgroup in serum of patients with rectal cancer 显示文摘	Chen J Xiang F Tang XJ	2011	Chinese German J Cl Onc2011，10，2：	1
16	Alcohol and alcohol-related harm in China:policy changes needed显示文摘	Tang YL Xiang XJ Wang XY Cubells JF Babor TF Hao W		0，，04：	1
17	A phase Ⅱ study of capecitabine plus oxaliplatin as first - line chemotherapy in elderly patients with advanced gastric cancer显示文摘	Xiang XJ Zhang L Qiu F	2012	Chemotherapy2012，58，1：	1
18	Protective effects of Salvia plebeia compound homoplantaginin on hepatocyte injury显示文摘	Qu XJ Xia X Wang YS Song MJ Liu LL Xie YY Cheng YN Liu XJ Qiu LL Xiang L Gao JJ Zhang XF Cui SX		0，，：	1
19	A phase Ⅱ study of capecitabine plus oxaliplatin as first - line chemotherapy in elderly patients with advanced gastric cancer 显示文摘	Xiang XJ Zhang L Qiu F	2012	Chemotherapy2012，58，1：	1
20	A phase II study of modified FOLFOX as first-line chemotherapy in advanced small bowel adenocarcinoma显示文摘	Xiang XJ Liu YW Zhang L	2012	Anticancer Drugs2012，23，5：	1

返回顶部每页显示：

共2页首页上一页第1页下一页末页 /2 跳转

互联网出版许可证新出网证(渝)字10号全国400电话 - 免长途话费

用户提示